Niagen Bioscience, Inc. (NAGE) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-04 19:12:13 ET
Niagen Bioscience, Inc. (NAGE) Q4 2025 Earnings Call March 4, 2026 4:30 PM EST
Company Participants
Kendall Knysch - Head of Media Relations & Partnerships
Robert Fried - CEO & Director
Andrew Shao - Senior Vice President of Global Regulatory & Scientific Affairs
Ozan Pamir - CFO & Principal Accounting Officer
Lauren Rittman-Borzansky
...
Read the full article on Seeking Alpha
For further details see:
Niagen Bioscience, Inc. (NAGE) Q4 2025 Earnings Call Transcript
Niagen Bioscience Inc.
NASDAQ: NAGE
NAGE Trading
4.8% G/L:
$5.235 Last:
988,442 Volume:
$4.925 Open:
NAGE Latest News
NAGE Stock Data
$408,607,432
52,743,877
N/A
66
N/A
Biotechnology & Life Sciences
Healthcare
US
Los Angeles
